AK
Anil Kumar Jain
About Anil Kumar Jain
Data last updated:
Anil Kumar Jain was a Director at Matrix Pharmacorp Private Limited (2024–2025), Managing Director at Pi Health Sciences Limited (2022–2024) and Director at Tianish Laboratories Private Limited (from 2024), and held 2 more directorships. The companies operate in Pharma.
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Matrix Pharmacorp Private Limited U33110TG2022PTC167288 | Director | 30 Sep 2024 | 2022 | ₹4,422 Cr (FY 2025) | Active |
| Pi Health Sciences Limited U24290RJ2021PLC076803 | Managing Director | 22 Aug 2022 | 2021 | ₹247 Cr (FY 2025) | Active |
| Tianish Laboratories Private Limited U21001TS2023PTC171372 | Director | 22 Oct 2024 | 2023 | ₹2,060 Cr (FY 2024) | Amalgamated |
 Therachem Research Medilab (India) Private Limited U24232RJ2006PTC023466 | Director | 02 Jun 2023 | 2006 | ₹194 Cr (FY 2023) | Amalgamated |
| Solis Pharmachem Private Limited U24100GJ2019PTC111161 | Director | 02 Jun 2023 | 2019 | ₹4.25 Cr (FY 2023) | Amalgamated |
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Anil Kumar Jain
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Anil Kumar Jain
Anil Kumar Jain was first appointed on 22 Aug 2022 as Managing Director at Pi Health Sciences Limited. The most recent appointment on record is 22 Oct 2024 at Tianish Laboratories Private Limited.
Anil Kumar Jain held 5 earlier board appointments: Matrix Pharmacorp Private Limited (Director, 30 Sep 2024 to 24 Sep 2025); Pi Health Sciences Limited (Managing Director, 22 Aug 2022 to 05 Jul 2024); Tianish Laboratories Private Limited (Director, from 22 Oct 2024); Therachem Research Medilab (India) Private Limited (Director, from 02 Jun 2023); Solis Pharmachem Private Limited (Director, from 02 Jun 2023).